Archive for: Regulatory

Diagonal Bio AB’s warrant exercise registered at the Swedish Companies Registration Office

, , ,
Diagonal Bio AB ("Diagonal" or the "Company") today announces that the new shares from the exercise of warrants of series TO 1 have been registered with the Swedish Companies Registration Office.On 26 September 2024, the exercise period for…

Diagonal Bio AB announces the outcome of the exercise of warrants of series TO 1

, , ,
On September 26, 2024, the exercise period for Diagonal Bio AB's ("Diagonal" or the "Company") warrants of series TO 1 ("TO 1") ended. A total of 77.794 warrants of series TO 1 have been exercised to subscribe for 77.794 shares, corresponding…

The exercise price for warrants of series TO 1 has been set to SEK 0,05 per new share

, , ,
Diagonal Bio AB ("Diagonal Bio" or "the Company") hereby announces that the exercise price for the warrants of series TO 1 (”TO 1”), which were issued in connection with the rights issue of units that the Company executed earlier…

Diagonal Bio announces successful external validation of LAMPlify® for respiratory viruses in horses

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” and “the Company”) announces that its diagnostic tool, LAMPlify® has undergone a successful external validation in accordance with ISO 17025 standards. It is confirming that…

Diagonal Bio AB Second Quarter Report (Q2 2024)

, , , , , , ,
“In the second quarter of 2024, we have made advancements, particularly within the equine healthcare sector (horse veterinary clinics) where our connections and the interest in our Point-of-Care instrument continue to deepen.”Summary…

Diagonal Bio receives order from the Technical University of Denmark

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has secured an order from the Technical University of Denmark (“DTU”) valued at just over 210,000 SEK for fish farms’ health project HURTIGFISK.…

Bulletin from the Annual General Meeting on 11 June 2024 in Diagonal Bio AB

, , ,
Today, on 11 June 2024, the Annual General Meeting of Diagonal Bio AB was held. A summary of the adopted resolutions follows below.Resolution on adoption of the accounts and appropriation of profitThe Annual General Meeting resolved to adopt…

Kommuniké från årsstämma den 11 juni 2024 i Diagonal Bio AB

, , ,
Idag, den 11 juni 2024, hölls årsstämma i Diagonal Bio AB. Nedan följer en sammanfattning av de beslut som fattades. Beslut om fastställande av räkenskaper samt resultatdispositionÅrsstämman beslutade…

Diagonal Bio AB first quarter (Q1 2024)

, , , , , ,
“The end of last year was marked by our focus on creating the business platform to generate the company's initial revenue in 2024. We continue and gear up on the set path with a focus on generating revenue”.Summary of Q1 report 20242024-01-01…

Diagonal Bio appoints new CFO

, , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has appointed Fata Mrsic as the new Chief Financial Officer (CFO). Fata will assume the position on June 14, 2024, and be part of the Management Team.Fata Mrsic…